Cathie Wood-led Ark Investment Management loaded up on 50,263 shares of Teladoc Health Inc (NYSE: TDOC), via the firm’s ARK Genomic Revolution ETF (NYSE: ARKG), valued at over $1.7 mi
Cathie Wood-led Ark Investment Management dumped over 293,000 shares of NVIDIA Corporation (NASDAQ: NVDA) on Tuesday via two of the firm’s exchange-traded funds.
On August 22, BlackRock Inc (NYSE: BLK) unveiled three new fixed income exchange traded funds, offering investors a BuyWrite strategy on fixed income assets.
Cathie Wood-led Ark Investment Management bought 311,073 Teladoc Health Inc (NYSE: TDOC) shares valued at over $11 million, through four of its exchange-traded funds, according to the firm's trading disclosure.
The SPDR S&P 500 (NYSE: SPY) spiked higher Wednesday afternoon after Fed minutes showed that officials agreed to keep hiking rates enough to cool down the economy in their meeting last month.
Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds (ETF) valued at over $20 million based on Thursday’s closing pri
Cathie Wood-led Ark Investment Management bought 129,800 shares of healthcare company Teladoc Health Inc (NYSE: TDOC), valued at over $4.5 million, based on Tuesday’s closing price, via four of its exchange-traded funds (ETFs).
Cathie Wood-led Ark Investment Management on Monday bought 366,982 shares of NVIDIA Corporation (NASDAQ: NVDA) valued at nearly $65.3 million, based on Monday’s closing price, via three of its exchange-traded funds.
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.